Call for Abstract

16th International Conference and Exhibition on Pharmaceutical Formulations, will be organized around the theme “Crystallization of Pharmaceutical Ingredients and Formulations”

Formulations 2018 is comprised of 18 tracks and 110 sessions designed to offer comprehensive sessions that address current issues in Formulations 2018.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Pharmaceutical excipients are those substances other than the prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. There are many excipients. Few of them include Antiadherents, Binders, Coatings, Colors, Flavours, Lubricants, Preservatives, Sweeteners etc.

  • Track 1-1Active ingredient of a medication
  • Track 1-2Surfactants and glidants
  • Track 1-3Emulsifying and suspending agents
  • Track 1-4Disintergants and binders
  • Track 1-5Preservatives and antioxidents
  • Track 1-6Diluents and lubricants
  • Track 1-7Stability enhancers

Entrepreneurs who are ready to invest and get profit by working hard in the field of pharmaceutical formulations will be happy by attending this meeting and make their way a successful one by meeting intellectuals and experts who can make their investment worthwhile. This platform will be the best one to make a shape of your business.

  • Track 2-1Profit and loss in the production
  • Track 2-2Risks in production and sales

Pharma industries are showing increased confidence in the growth of manufacturing in the market. This turn around in the market is due to the potential which is being driven by concerns of quality in some Asian markets and a marketed shift in the drug development. The primary reason behind this is an increased regulatory confidence in the standards of manufacturing.

  • Track 3-1Development in drug production and sales
  • Track 3-2Growth in Export and Imports
  • Track 3-3Environment for industry

Regulatory affairs are a new profession which is developed by the governments to protect public health. The main aim is controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals and cosmetics. Regulatory affairs also have a very specific meaning within the healthcare industries.

  • Track 4-1Intellectual property management
  • Track 4-2New drug discovery/development
  • Track 4-3Regulatory & pharmacovigilance
  • Track 4-4Regulatory challenges for medical device
  • Track 4-5Global Regulatory Intelligence
  • Track 4-6Regulatory Strategies and Developments
  • Track 4-7Clinical Affairs & Regulatory Strategies

Pharmacists can play a role helping patients with chronic diseases have better medication at correct time and get good clinical outcomes.  They play a key role in immunization services and identifying vaccine candidates. They Participate and maintain a significant role in multidisciplinary patient care rounds. Patients often make their own decisions about managing their medications. Pharmacists could usefully serve as patient advocates, providing information that permits patients to assess risk and enhance their autonomy.

  • Track 5-1Key role in reducing adverse drug events
  • Track 5-2Patient councelling
  • Track 5-3Communication barriers
  • Track 5-4Medical controversies
  • Track 5-5Legal and practical aspects of prescribing
  • Track 5-6Improving patient care in rural areas
  • Track 5-7Reducing healthcare costs
  • Track 5-8Improving patient safety

Targeted drug delivery sometimes called smart drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to other parts in the meantime reduce side effects/toxicity of payloads which are key factors for improving patient compliance.

  • Track 6-1Mucosal drug delivery
  • Track 6-2Gene delivery
  • Track 6-3Nucleic acid based drug delivery systems
  • Track 6-4Blood brain barrier delivery
  • Track 6-5Self-emulsifying drug delivery systems
  • Track 6-6Insulin dlivery
  • Track 6-7Targeted drug delivery
  • Track 6-8Proteins and surfaces

The drug product manufacturing facility is designed to produce injectable in syringes or vials in Grade A environment. Industries strive to improve product quality in today’s competitive environment and as well reduce the production cost.

  • Track 7-1Sterile filteration,aseptic filling
  • Track 7-2Process development tools
  • Track 7-3Stability testing
  • Track 7-4Capping, Sealing & Labelling
  • Track 7-5Storage and handling of cold-chain products
  • Track 7-6Pre and post gas flushing facility

Pharmaceutical analysis is a branch of practical chemistry that involves a series of process for qualification, purification, identification and determination of a substance, separation of the components of a solution or mixture, or determination of structure of chemical compounds. The sample to be analysed is called as analyse.

  • Track 8-1Quality control and quality assurance
  • Track 8-2Chromatographic techniques
  • Track 8-3Quantative and qualitative analysis
  • Track 8-4Validation methods
  • Track 8-5Stoichiometry between reactants & products

Drug design, also known as rational drug design, is the inventive process of finding new medications based on the knowledge of a biological target. Drug design defines the design of molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.

  • Track 9-1Ligand based drug designs
  • Track 9-2Structure based drug designs
  • Track 9-3Pre-clinical phase
  • Track 9-4Clinical phase
  • Track 9-5Cost
  • Track 9-6Valuation
  • Track 9-7Novel initiatives
  • Track 9-8Success rate

Pharmaceutical formulation is defined as the process in which different chemical substances are combined to produce a final medicinal product. The formulation studies involve developing a preparation of drug acceptable for patient. Formulation is the word often used in a way that includes dosage form. Formulation studies consider factors such as solubility, particle size, polymorphism and pH as all of these can influence bioavailability and hence the activity of a drug.

  • Track 10-1Formulation and preformulation
  • Track 10-2Developing a preparation of the drug
  • Track 10-3Formulation types
  • Track 10-4Formulation from plant sources
  • Track 10-5Quality of Formulation

The drug subjected to drug development undergoes number of trials and are screened at different stages to produce a final potent drug for the treatment of various diseases. During this process different properties are checked to see whether the drug is non-toxic to living system and is therapeutic or not. Using suitable excipients and technological preparations the active substances are formulated into final dosage form. The final product is the Actual composition of preparation, manufacturing specification.

  • Track 11-1Types of coating and coating procedures
  • Track 11-2Validation process
  • Track 11-3Advanced formulation techniques
  • Track 11-4Development of Parenteral dosage form
  • Track 11-5Development of oral dosage form
  • Track 11-6Lyophilized dosage forms
  • Track 11-7New chemical entity development

Prior to formulation some physico chemical properties are characterized. Chemical properties include structure, form and reactivity. Physical properties include particle size, melting point and solubility. In case of some drugs biological properties are also characterized. Age and sex of the patient also play a major role in dosage design. The others factors are Solubility, Buffer capacity and partition coefficient.

  • Track 12-1Physical and chemicals considerations.
  • Track 12-2Buffer capacity
  • Track 12-3Partition coeficient
  • Track 12-4Solubility and PH
  • Track 12-5The phase rule
  • Track 12-6Melting point depression
  • Track 12-7Age and sex of patient

“Novel Drug delivery System (NDDS) refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.

  • Track 13-1Nano technology
  • Track 13-2Controlling pharmacokinetics and dynamic properties
  • Track 13-3Drug Delivery Carriers, Micelles, etc..,,
  • Track 13-4Types of dosage forms
  • Track 13-5Route of administration

Formulations are classified into two types: based on Route of administration and Physical form. Based on route of administration they are classified as Oral, Topical, Rectal, Parenteral, Vaginal, Inhaled, Ophthalmic and octic

  • Track 14-1Types: Parenteral,Topical, Enternal
  • Track 14-2Routes of administration: Oral, Rectal,Vaginal, Lingual etc
  • Track 14-3Inhalation formulations
  • Track 14-4Formulation from plant sources
  • Track 14-5Other routes
  • Track 14-6Advantages and disadvantages

Gaseous dosage forms are packed in a container which gets released upon applying pressure. The gas inside contains therapeutically active medicaments. The containers have valve systems with continuous or limited delivery. They are used for topical application on skin and as local application into nose and mouth. Ex: Nebulizer, Sprays, Inhalers., April 11-13, 2017 Seoul, South Korea.

  • Track 15-1Sprays
  • Track 15-2Vaporizer
  • Track 15-3Aerosols
  • Track 15-4Nebulizer or atomizer
  • Track 15-5Inhalers

Liquid dosage forms are essential pharmaceutical products which involves a mixture of active drug components and nondrug components (excipients). Liquid dosage forms are prepared: a) by dissolving the active drug substance in an aqueous or non- aqueous (e.g. glycerin, ether, alcohol) solvent b) By suspending the drug in appropriate medium or c) By incorporating the drug substance into an oil or water phase. Ex: Suspension, Emulsion, Syrups, Elixers

  • Track 16-1Syrups/Suspension/Emulsion
  • Track 16-2Preparation methods
  • Track 16-3Used mainly for elderly and young children
  • Track 16-4Oral Drops
  • Track 16-5Elixirs
  • Track 16-6Linctuses
  • Track 16-7Gargles
  • Track 16-8Advantages and disadvantages

Semi solid dosage forms are the products when applied to the skin treat a pathological condition and protects from other harmful environment. They are smooth,non-staining and get miscible with skin secretions. Creams, Gels, Pastes etc. are the examples.

  • Track 17-1Ointments,Creams
  • Track 17-2Industrial processing
  • Track 17-3Storage conditions
  • Track 17-4Ideal properties
  • Track 17-5Formulation

Solid dosage formulations are important dosage forms in pharmaceuticals. e.g. tablets, capsules, granules, sachets, reconstitutable powders, powders, dry powder inhalers and chewables. Solid dosage form contains unit dose of one or more medicament. Excipients include Binders, Glidants, Sweeteners etc.,

  • Track 18-1Granulated formulations
  • Track 18-2Types of Preparations
  • Track 18-3Chewable tablets
  • Track 18-4Capsules
  • Track 18-5Pills
  • Track 18-6Lozenges
  • Track 18-7Dental cones
  • Track 18-8Granules